Keyphrases
Gene Expression Profiling
100%
Brain Metastases
100%
Early-stage Lung Cancer
100%
Metastasis
27%
Non-small Cell Lung Cancer (NSCLC)
27%
Primary Tumor
18%
Oxidative Phosphorylation Pathway
18%
Gene Expression
9%
Signaling Pathway
9%
Clinically Significant
9%
Expression Level
9%
Principal Coordinate Analysis (PCoA)
9%
Organ-specific
9%
Disease Stage
9%
Brain Development
9%
Specific Pattern
9%
Strong Correlation
9%
Internal Validation
9%
RNA Sequencing (RNA-seq)
9%
Gene Signature
9%
Cancer Mortality
9%
Metastasis Formation
9%
Surgical Specimen
9%
Surgical Resection
9%
Metastatic Spread
9%
Working Diagnosis
9%
Most Common Cause
9%
Clinical Parameters
9%
Cancer Causes
9%
Metastatic Disease
9%
Small Sets
9%
Leave-one-out
9%
Novel Therapeutic Targets
9%
Early Metastatic
9%
Brain Control
9%
Disease Spread
9%
Pathway Enrichment
9%
Metastasis Prevention
9%
Metastasis Risk
9%
Validation Analysis
9%
Tumor Bank
9%
Spread Pattern
9%
Illumina HiSeq 2500
9%
Enrichment Study
9%
Biochemistry, Genetics and Molecular Biology
Gene Expression Profiling
100%
Oxidative Phosphorylation
100%
Gene Expression
50%
RNA
50%
Principal Component Analysis
50%
Cancer Mortality
50%
RNA Sequence
50%
Medicine and Dentistry
Gene Expression Profiling
100%
Brain Metastasis
100%
Non Small Cell Lung Cancer
100%
Metastatic Carcinoma
36%
Primary Tumor
18%
Oxidative Phosphorylation
18%
Diseases
18%
Gene Expression
9%
Neoplasm
9%
Cancer Mortality
9%
Principal Component Analysis
9%
RNA Sequence
9%
Cell Signaling Pathway
9%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Metastasis
100%
Non Small Cell Lung Cancer
100%
Primary Tumor
18%
Diseases
18%
Neoplasm
9%
Cancer Mortality
9%
RNA-Sequencing
9%